Wird geladen...
Clinical potential of midostaurin in advanced systemic mastocytosis
Advanced (Ad) systemic mastocytoses (SM) include aggressive SM (ASM) and mast cell leukemia (MCL) with or without an associated clonal hematological non-mast cell lineage disease (AHNMD). They are rare (<15%) but are associated with a poor prognosis due to rapid organ dysfunction. To date, respon...
Gespeichert in:
| Veröffentlicht in: | Blood Lymphat Cancer |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6467340/ https://ncbi.nlm.nih.gov/pubmed/31360083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S87186 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|